Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell LymphomaStefan Koeck, Thomas Melchardt, Natalia Rotter et al.|Transplantation and Cellular Therapy|2026Cited by 1
A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life settingAndreas Petzer, Peter Valent, Albert Wölfler et al.|Wiener klinische Wochenschrift|2020Cited by 0
Comparative analysis of ide-cel and cilta-cel in patients with Relapsed/Refractory multiple myeloma: A nationwide, retrospective, real-world analysis across AustriaIrene Straßl, Krauth Maria-Theresa, Alexander Nikoloudis et al.|Blood|2025Cited by 0